{"id":4979,"date":"2018-06-01T13:25:21","date_gmt":"2018-06-01T06:25:21","guid":{"rendered":"https:\/\/www.oucru.org\/?p=4979"},"modified":"2023-01-14T10:11:56","modified_gmt":"2023-01-14T03:11:56","slug":"old-drug-new-role-elife-podcast","status":"publish","type":"post","link":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/","title":{"rendered":"Old drug, new role &#8211; eLife podcast"},"content":{"rendered":"<p>We recently reported the <a href=\"https:\/\/elifesciences.org\/articles\/33478\">exciting findings published in eLife<\/a>, from a phase II clinical trial led by <a href=\"https:\/\/www.oucru.org\/guy-thwaites\/\">Professor Guy Thwaites<\/a> which showed that aspirin\u00a0help increase survival from\u00a0TB meningitis by reducing brain inflammation and preventing the disease from blocking blood vessels in the brain that cause parts of the brain to die (commonly called \u2018stroke\u2019).<\/p>\n<p>With funding from the\u00a0<a href=\"https:\/\/wellcome.ac.uk\/\">Wellcome Trust<\/a>, OUCRU researchers \u00a0investigated whether the addition of aspirin at low (81mg\/day) or high (1000mg\/day) dose, or placebo, to the first 60 days of current standard TB meningitis treatment (anti-TB drugs and steroids) was safe and reduced new strokes or death from this severe disease.<\/p>\n<p>Professor Thwaites was recently interviewed about this work for the eLife podcast, and you can listen that interview here:\u00a0<a href=\"https:\/\/elifesciences.org\/articles\/33478\">eLife podcast<\/a><\/p>\n<p>eLife have also published an insight article, which discusses this study and its results, available online <a href=\"https:\/\/elifesciences.org\/articles\/35906\">here<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We recently reported the exciting findings published in eLife, from a phase II clinical trial led by Professor Guy Thwaites which showed that aspirin\u00a0help increase survival from\u00a0TB meningitis by reducing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":"","_wp_rev_ctl_limit":""},"categories":[79],"tags":[],"class_list":["post-4979","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Old drug, new role - eLife podcast - OUCRU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Old drug, new role - eLife podcast - OUCRU\" \/>\n<meta property=\"og:description\" content=\"We recently reported the exciting findings published in eLife, from a phase II clinical trial led by Professor Guy Thwaites which showed that aspirin\u00a0help increase survival from\u00a0TB meningitis by reducing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\" \/>\n<meta property=\"og:site_name\" content=\"OUCRU\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OUCRUVN\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-01T06:25:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-14T03:11:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oucru.org\/wp-content\/uploads\/2022\/11\/img-fallback.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OUCRU_Programme\" \/>\n<meta name=\"twitter:site\" content=\"@OUCRU_Programme\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/person\/37dc99b679e5762b79e51b07cc12fff4\"},\"headline\":\"Old drug, new role &#8211; eLife podcast\",\"datePublished\":\"2018-06-01T06:25:21+00:00\",\"dateModified\":\"2023-01-14T03:11:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\"},\"wordCount\":153,\"publisher\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"id\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\",\"url\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\",\"name\":\"Old drug, new role - eLife podcast - OUCRU\",\"isPartOf\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#website\"},\"datePublished\":\"2018-06-01T06:25:21+00:00\",\"dateModified\":\"2023-01-14T03:11:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oucru.org\/id\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Old drug, new role - eLife podcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oucru.org\/id\/#website\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"name\":\"OUCRU\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\"},\"alternateName\":\"Oxford University Clinical Research Unit (OUCRU)\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oucru.org\/id\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\",\"name\":\"Oxford University Clinical Research Unit.\",\"alternateName\":\"OUCRU\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"contentUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"width\":512,\"height\":333,\"caption\":\"Oxford University Clinical Research Unit.\"},\"image\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OUCRUVN\/\",\"https:\/\/x.com\/OUCRU_Programme\",\"https:\/\/www.linkedin.com\/company\/oucru\/\",\"https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/person\/37dc99b679e5762b79e51b07cc12fff4\",\"name\":\"admin\",\"url\":\"https:\/\/www.oucru.org\/id\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Old drug, new role - eLife podcast - OUCRU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/","og_locale":"id_ID","og_type":"article","og_title":"Old drug, new role - eLife podcast - OUCRU","og_description":"We recently reported the exciting findings published in eLife, from a phase II clinical trial led by Professor Guy Thwaites which showed that aspirin\u00a0help increase survival from\u00a0TB meningitis by reducing [&hellip;]","og_url":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/","og_site_name":"OUCRU","article_publisher":"https:\/\/www.facebook.com\/OUCRUVN\/","article_published_time":"2018-06-01T06:25:21+00:00","article_modified_time":"2023-01-14T03:11:56+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2022\/11\/img-fallback.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@OUCRU_Programme","twitter_site":"@OUCRU_Programme","twitter_misc":{"Ditulis oleh":"admin","Estimasi waktu membaca":"1 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#article","isPartOf":{"@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/"},"author":{"name":"admin","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/person\/37dc99b679e5762b79e51b07cc12fff4"},"headline":"Old drug, new role &#8211; eLife podcast","datePublished":"2018-06-01T06:25:21+00:00","dateModified":"2023-01-14T03:11:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/"},"wordCount":153,"publisher":{"@id":"https:\/\/www.oucru.org\/id\/#organization"},"articleSection":["News"],"inLanguage":"id"},{"@type":"WebPage","@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/","url":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/","name":"Old drug, new role - eLife podcast - OUCRU","isPartOf":{"@id":"https:\/\/www.oucru.org\/id\/#website"},"datePublished":"2018-06-01T06:25:21+00:00","dateModified":"2023-01-14T03:11:56+00:00","breadcrumb":{"@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.oucru.org\/id\/old-drug-new-role-elife-podcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oucru.org\/id\/"},{"@type":"ListItem","position":2,"name":"Old drug, new role - eLife podcast"}]},{"@type":"WebSite","@id":"https:\/\/www.oucru.org\/id\/#website","url":"https:\/\/www.oucru.org\/id\/","name":"OUCRU","description":"","publisher":{"@id":"https:\/\/www.oucru.org\/id\/#organization"},"alternateName":"Oxford University Clinical Research Unit (OUCRU)","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oucru.org\/id\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/www.oucru.org\/id\/#organization","name":"Oxford University Clinical Research Unit.","alternateName":"OUCRU","url":"https:\/\/www.oucru.org\/id\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/","url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","contentUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","width":512,"height":333,"caption":"Oxford University Clinical Research Unit."},"image":{"@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OUCRUVN\/","https:\/\/x.com\/OUCRU_Programme","https:\/\/www.linkedin.com\/company\/oucru\/","https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618"]},{"@type":"Person","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/person\/37dc99b679e5762b79e51b07cc12fff4","name":"admin","url":"https:\/\/www.oucru.org\/id\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/4979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/comments?post=4979"}],"version-history":[{"count":1,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/4979\/revisions"}],"predecessor-version":[{"id":15692,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/4979\/revisions\/15692"}],"wp:attachment":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/media?parent=4979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/categories?post=4979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/tags?post=4979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}